Consuming a lot of alcohol has long been associated with heart problems, but a new study offers an uncharted perspective on “wet” counties versus “dry” counties and how living in either can affect cardiovascular health.

The…

Having a higher-than-normal body mass index (BMI) as a teenager could be an indicator that men will experience heart failure in middle age. That’s according to findings published in the European Heart Journal based on a…

Patients who suffer from type 2 diabetes and coronary heart disease could be in worse shape than doctors previously thought, say the authors of a new study published in the journal Diabetes Care.

The EXAMINE trial study…

A study published by Heart found that loneliness and social isolation are linked to a 30 percent increased risk of having a stroke or developing coronary…

Vericel Corp. announced on March 10 that its experimental drug to treat advanced heart failure due to ischemic dilated cardiomyopathy met the primary endpoint in a phase 2b clinical trial.

After a year of treatment, patients with end-stage…

Patients with chronic heart failure and high scores on a global self-care scale had similar rates of long-term, all-cause mortality compared with those with low scores, according to a secondary analysis from two observational prospective studies…

A model-based study found that patients with chronic heart failure who used the CardioMEMS device had reductions in hospitalizations and increases in quality-adjusted life-years (QALYs) and costs.

Based on the analysis, the CardioMEMS…

Novartis has entered into a pay-for-performance agreement with Cigna to cover sacubitril/valsartan (Entresto), a twice-daily oral medication to treat patients with heart failure and reduced ejection fraction.

Aetna also…

After a 20-week regimen that included an improved diet and/or an increased exercise regiment, obese, older adults with heart failure had an increase in exercise capacity, according to a randomized trial conducted at an urban academic medical…

After declining for more than a decade, the age-adjusted rate for heart failure-related deaths increased from 2012 to 2014, according to a recent data brief from the National Center for Health Statistics.

The trend was consistent for men…

A model developed to predict 30-day readmissions for heart failure found that having patients self-report their socioeconomic, health status and psychosocial characteristics did not improve the researchers’ ability to determine the readmissions…

An actuarial analysis found that patients who receive sacubitril/valsartan may have an increased life expectancy and reduced risk of death from cardiovascular causes or hospitalization for heart failure compared with patients who take enalapril…

The American College of Cardiology (ACC), Geisinger Health System and xG Health Solutions announced a new joint initiative to enhance the processes and outcomes of clinical care for patients with heart failure.

The three organizations will…

Although guidelines recommend against the use of pulmonary artery catheters for routine management of heart failure, physicians have significantly increased their use of pulmonary artery catheters in recent years, according to an analysis of…

Every year, more than 795,000 Americans suffer a stroke—with 665,000 people surviving the episode. The annual cost of stroke in the U.S. tops $33.6 billion (Circulation. 2015 ;e29-322.) and one out of six Americans will have a stroke in their…

The FDA sent a warning letter to St. Jude Medical regarding a facility in Atlanta where the company manufactures its CardioMEMS heart failure system. St. Jude Medical revealed the information in an 8-K filing to the Securities and Exchange…

Providing ambulatory heart failure patients with higher doses of beta-blockers significantly improved all-cause death or hospitalization, according to a multicenter, randomized, controlled trial.

The researchers found increasing the dosage…

Patients with heart failure and major depression who underwent cognitive behavior therapy had improvements in mental health and overall quality of life after six months, according to a randomized trial. However, the intervention did not improve…

An analysis of a randomized clinical trial found patients with cardiovascular disease and type 2 diabetes who received sitagliptin had similar rates of heart failure or other cardiovascular complications compared with a placebo group.

…

A clinical risk score helped predict the risk of ischemic stroke, thromboembolism and death in patients with heart failure, according to an analysis of three nationwide registries in Denmark. However, the researchers noted the predictive accuracy…

Only 10 percent of patients with heart failure were referred to cardiac rehabilitation after hospital discharge between 2005 and 2014, according to a database analysis.

Although the referral rates were higher in recent years, researchers…